Research Article
Impact of Immunochemotherapy-Related Hepatic Toxicity on the Outcome of HCV-Positive Diffuse Large B-Cell Lymphoma Patients
Table 2
The baseline laboratory values of both groups.
| Variable | HCV positive (group A) Mean ± standard deviation | HCV negative (group B) Mean ± standard deviation | value |
| WBC (cells/mm3) | 6.3 ± 2.1 | 6.2 ± 2.7 | 0.95 | Hemoglobin (g/dL) | 12.6 ± 0.8 | 11.2 ± 1.5 | 0.03* | Platelets (×103/mm3) | 276.9 ± 115.4 | 276.7 ± 104.3 | 0.99 | Bilirubin (mg/dL) | 0.9 ± 0.5 | 0.8 ± 0.2 | 0.48 | Albumin (mg/dL) | 4.0 ± 0.5 | 4.1 ± 0.4 | 0.49 | ALT (IU/L) | 55.0 ± 30 | 37.1 ± 15 | 0.14 | AST (IU/L) | 56.3 ± 30 | 40.6 ± 17 | 0.1 | INR | 1.2 ± 0.3 | 1.1 ± 0.2 | 0.23 | Creatinine (mg/dL) | 0.7 ± 0.1 | 0.8 ± 0.3 | 0.51 |
|
|
means significant ( < 0.05).
|